Literature DB >> 29181818

Correction for Partial Volume Effect Is a Must, Not a Luxury, to Fully Exploit the Potential of Quantitative PET Imaging in Clinical Oncology.

Abass Alavi1, Thomas J Werner2, Poul Flemming Høilund-Carlsen3, Habib Zaidi3,4,5,6.   

Abstract

The partial volume effect (PVE) is considered as one of the major degrading factors impacting image quality and hampering the accuracy of quantitative PET imaging in clinical oncology. This effect is the consequence of the limited spatial resolution of whole-body PET scanners, which results in blurring of the generated images by the scanner's response function. A number of strategies have been devised to deal with partial volume effect. However, the lack of consensus on the clinical relevance of partial volume correction and the most appropriate technique to be used in the context of clinical oncology limited their application in clinical setting. This issue is debated in this commentary.

Keywords:  Clinical oncology; PET; Partial volume correction; Partial volume effect; Quantification

Mesh:

Year:  2018        PMID: 29181818     DOI: 10.1007/s11307-017-1146-y

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  25 in total

1.  Feasibility and performance of novel software to quantify metabolically active volumes and 3D partial volume corrected SUV and metabolic volumetric products of spinal bone marrow metastases on 18F-FDG-PET/CT.

Authors:  Drew A Torigian; Rosa Fernandez Lopez; Sridevi Alapati; Geetha Bodapati; Frank Hofheinz; Joerg van den Hoff; Babak Saboury; Abass Alavi
Journal:  Hell J Nucl Med       Date:  2011 Jan-Apr       Impact factor: 1.102

2.  The effect of breathing irregularities on quantitative accuracy of respiratory gated PET∕CT.

Authors:  Boon-Keng Teo; Babak Saboury; Reshma Munbodh; Joshua Scheuermann; Drew A Torigian; Habib Zaidi; Abass Alavi
Journal:  Med Phys       Date:  2012-12       Impact factor: 4.071

3.  FDG PET/CT methodology for evaluation of treatment response in lymphoma: from "graded visual analysis" and "semiquantitative SUVmax" to global disease burden assessment.

Authors:  Sandip Basu; Habib Zaidi; Ali Salavati; Søren Hess; Poul Flemming Høilund Carlsen; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-07-04       Impact factor: 9.236

Review 4.  PET imaging in oncology.

Authors:  R Bar-Shalom; A Y Valdivia; M D Blaufox
Journal:  Semin Nucl Med       Date:  2000-07       Impact factor: 4.446

5.  Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.

Authors:  Ali Salavati; Samuel Borofsky; Teo K Boon-Keng; Sina Houshmand; Benjapa Khiewvan; Babak Saboury; Ion Codreanu; Drew A Torigian; Habib Zaidi; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

6.  Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia.

Authors:  N K Tanna; M I Kohn; D N Horwich; P R Jolles; R A Zimmerman; W M Alves; A Alavi
Journal:  Radiology       Date:  1991-01       Impact factor: 11.105

7.  Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.

Authors:  A Alavi; A B Newberg; E Souder; J A Berlin
Journal:  J Nucl Med       Date:  1993-10       Impact factor: 10.057

Review 8.  Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis.

Authors:  Marc R Dweck; Elena Aikawa; David E Newby; Jason M Tarkin; James H F Rudd; Jagat Narula; Zahi A Fayad
Journal:  Circ Res       Date:  2016-07-08       Impact factor: 17.367

Review 9.  Meta-analysis: pitfalls and hints.

Authors:  T Greco; A Zangrillo; G Biondi-Zoccai; G Landoni
Journal:  Heart Lung Vessel       Date:  2013

10.  18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

Authors:  Nikhil V Joshi; Alex T Vesey; Michelle C Williams; Anoop S V Shah; Patrick A Calvert; Felicity H M Craighead; Su Ern Yeoh; William Wallace; Donald Salter; Alison M Fletcher; Edwin J R van Beek; Andrew D Flapan; Neal G Uren; Miles W H Behan; Nicholas L M Cruden; Nicholas L Mills; Keith A A Fox; James H F Rudd; Marc R Dweck; David E Newby
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

View more
  10 in total

1.  PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.

Authors:  Oke Gerke; Karen Ehlers; Edith Motschall; Poul Flemming Høilund-Carlsen; Werner Vach
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

2.  Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy.

Authors:  Raheleh Taghvaei; Mahdi Zirakchian Zadeh; Reza Sirous; Sara Pourhassan Shamchi; William Y Raynor; Siavash Mehdizadeh Seraj; Mateen Moghbel; Shiyu Wang; Thomas J Werner; Hongming Zhuang; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

3.  A Multi-Atlas-Based [18F]9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography Image Segmentation Method for Parkinson's Disease Quantification.

Authors:  Yiwei Pan; Shuying Liu; Yao Zeng; Chenfei Ye; Hongwen Qiao; Tianbing Song; Haiyan Lv; Piu Chan; Jie Lu; Ting Ma
Journal:  Front Aging Neurosci       Date:  2022-06-13       Impact factor: 5.702

4.  A Novel PET Probe for Brown Adipose Tissue Imaging in Rodents.

Authors:  Hui Wang; Mengzhe Wang; Kantapat Chansaenpak; Yang Liu; Hong Yuan; Jin Xie; Hang Yin; Rosa T Branca; Zibo Li; Zhanhong Wu
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

5.  A systematic optimization of 19F MR image acquisition to detect macrophage invasion into an ECM hydrogel implanted in the stroke-damaged brain.

Authors:  Harmanvir Ghuman; T Kevin Hitchens; Michel Modo
Journal:  Neuroimage       Date:  2019-08-10       Impact factor: 6.556

6.  Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not.

Authors:  Abass Alavi; Thomas J Werner; Poul Flemming Høilund-Carlsen; Mona-Elisabeth Revheim
Journal:  Clin Nucl Med       Date:  2022-04-05       Impact factor: 10.782

7.  Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics.

Authors:  M C F Cysouw; S V S Golla; V Frings; E F Smit; O S Hoekstra; G M Kramer; R Boellaard
Journal:  EJNMMI Res       Date:  2019-02-04       Impact factor: 3.138

8.  Global disease score (GDS) is the name of the game!

Authors:  Poul F Høilund-Carlsen; Lars Edenbrandt; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-10       Impact factor: 9.236

9.  Fusion and Healing Prediction in Posterolateral Spinal Fusion Using 18F-Sodium Fluoride-PET/CT.

Authors:  Caius M Constantinescu; Michael K Jacobsen; Oke Gerke; Mikkel Ø Andersen; Poul F Høilund-Carlsen
Journal:  Diagnostics (Basel)       Date:  2020-04-16

10.  FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.

Authors:  Tomohiro Kameda; Shusaku Nakashima; Katsuya Mitamura; Yuka Yamamoto; Takashi Norikane; Hiromi Shimada; Risa Wakiya; Mikiya Kato; Taichi Miyagi; Koichi Sugihara; Rina Mino; Mao Mizusaki; Norimitsu Kadowaki; Hiroaki Dobashi
Journal:  Sci Rep       Date:  2022-09-13       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.